ALTB-268
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ALTB-268, covering 2026-01-02 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants [Phase 1]